Loading...
Dual blockade of HER2 in HER2-overexpressing tumor cells does not completely eliminate HER3 function
PURPOSE: Dual blockade of HER2 with trastuzumab with lapatinib or with pertuzumab is a superior treatment approach compared to single agent HER2 inhibitors. However, many HER2-overexpressing breast cancers still escape from this combinatorial approach. Inhibition of HER2 and downstream phosphatidyli...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563762/ https://ncbi.nlm.nih.gov/pubmed/23224399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2024 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|